Latest from the Clostridium difficile research community. Edited by @nataszahain
Perth, Western Australia
Joined August 2016
- Tweets612
- Following163
- Followers492
- Likes393
C. difficile Papers retweeted
A new antimicrobial peptide designed based on Clostridioides difficile IF1 shows broad-spectrum inhibitory activities against C. difficile and other bacterial strains. journals.asm.org/doi/10.1128…
C. difficile Papers retweeted
In @CIDJournal, Pablo Okhuysen, MD, FACP, FIDSA, and colleagues aim to confirm the superiority of ridinilazole over vancomycin on Sustained Clinical Response and recurrent CDI as reported in a Phase II Study.
Read: idsajournals.link/2OufYh
C. difficile Papers retweeted
Friday Celebrations! Chenlin Hu, PhD and @GareyKgarey published a review of microscopy methods for C. difficile in Anaerobe! 🔬🦠
Check it out ⬇️⬇️
doi.org/10.1016/j.anaerobe.2…
@AnaerobeSociety @UH_Pharmacy
C. difficile Papers retweeted
🌟And the publications keep coming!🌟
Check out our labs most recent work on ibezapolstat activity against MDR C. difficile strains ⬇️⬇️
doi.org/10.1128/aac.01621-23
TLDR: IBZ bactericidal activity was similar to the MIC and maintained in wild-type and non-susceptible strains. – at Houston, TX
C. difficile Papers retweeted
🆕️🔥Multicenter cohort study included adults with C. difficile infection @CIDJournal
Vancomycin MIC >2 μg/mL in Clostridioides difficile was associated with decreased odds of 30-day sustained clinical response & lower 14-day initial cure rates #IDXposts academic.oup.com/cid/article…
C. difficile Papers retweeted
It's not just about age anymore. #Clostridioidesdifficile infection is reaching beyond traditional risk groups. #guthealth #Cdiff
C. difficile Papers retweeted
Clindamycin attacking the normal flora 🥊 teapawt.org/Yoda4ever/status/17430…
C. difficile Papers retweeted
Pleased to share this publication on vaccine potential of Salmonella against C. difficile in a mouse model: a collaboration with Brian Ward and Ph. D. student Kaitlin Winter @MIMM_McGill and my group @inrsciences @infectiopole. Out in Microbiol. Spectrum: journals.asm.org/doi/10.1128…
C. difficile Papers retweeted
Have you seen this new @AmCollegeGastro monograph on microbiome therapeutics?
✅ Essential aspects of methods for analyzing the microbiome
✅ Present and future therapeutics for C. difficile
✅ Non-prescription therapeutics
👉 journals.lww.com/ajg/toc/202…
C. difficile Papers retweeted
New findings shed light on the key #microbes that protect against recurrent #Clostridiodes difficile infection and #MultipleSclerosis, pointing to future treatment opportunities with live #biotherapeutics. Read more: mshs.co/3Q9ZZdH
#Immunology
C. difficile Papers retweeted
Happy to share the latest preprint from the @StadtmuellerLab - an incredible effort by recent PhD student @Sonya31397350! Engineered Secretory Immunoglobulin A provides insights on antibody-based effector mechanisms targeting Clostridiodes difficile biorxiv.org/content/10.1101/…
Fecal Microbiota Transplantation: Information for the Pediatrician
publications.aap.org/pediatr…
Genetic variation in the human leukocyte antigen region confers susceptibility to Clostridioides difficile infection
nature.com/articles/s41598-0…
Update on Microbiota-derived therapies for recurrent Clostridioides difficile infections, 2023
sciencedirect.com/science/ar…
C. difficile Papers retweeted
C. Diff: Professors Suggest Inflammation, Not Bacteria Should be Targeted bit.ly/4akb9UH #CDiff #ClostridioidesDifficile
C. difficile Papers retweeted
Grat to Jannie and CMAT for this study on bacterial and fungal microbiome interactions in patients colonized or infected with Cdiff. @EurFmt
@CMIJournal @SmitsLab
oaepublish.com/articles/mrr.…
C. difficile Papers retweeted
The role of gut fungi in #Clostridioides difficile infection
sciencedirect.com/science/ar… #OpenAccess #mycology #Cdiff
C. difficile Papers retweeted
🆕🔥Our study on C. difficile infections among allogeneic HCT recipients in the framework of the Swiss Transplant Cohort Study🇨🇭@BMTjournal @TheEBMT
A short summary 🔽1/5 #IDTwitter nature.com/articles/s41409-0…
Doxycycline tied to lower risk for C. difficile in pneumonia patients
medicalxpress.com/news/2023-…
Could a Breath biopsy be used for C. difficile diagnosis in the future?
Breath Biopsy and Discovery of Exclusive Volatile Organic Compounds for Diagnosis of Infectious Diseases
ncbi.nlm.nih.gov/pmc/article…